ClinicalTrials.gg
CompletedNCT04055675Updated Jun 18, 2020Results posted

Urinalysis Results in Healthy Individuals

An observational study in Asymptomatic Bacteriuria and Asymptomatic Pyuria, sponsored by Kendall Healthcare Group, Ltd.. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-06-18.

Sponsored by Kendall Healthcare Group, Ltd. · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective, observational study assessing the results of urine dipsticks on adult volunteers with no acute symptoms. We seek to determine the frequency of leukocytes or nitrites in this group of individuals.

Read the detailed description

The urinalysis (UA) is one of the most commonly utilized tests in the emergency department (ED). In some busy EDs, a UA is routinely ordered by protocol on patients with abdominal pain, and in elderly patients, a UA is often ordered for a variety of chief complaints including dizziness and altered mental status. When these patients, who often do not specifically have symptoms of a urinary tract infection, have a urinalysis demonstrating pyuria or bacteria, it may be interpreted as an atypical presentation of a UTI. However, it is possible that these patients do not have urinary tract infections, but have baseline pyuria or bacteriuria. One prior study found that 5% of sexually active healthy women 18-40 have asymptomatic bacteriuria [1], and the rate of asymptomatic bacteriuria increases with age, such that it is present in 8-10% of women from 70-80 years of age [2]. Moreover, one prior article stated that 30-50% of residents of long term nursing facilities have positive urine cultures at any given time [3].

The above statistics come from the results of urine cultures. In the ED, the decision to treat or not treat a patient for a UTI is not made based upon culture results, but upon a urinalysis (microscopic or dipstick). Only one prior study has looked at the frequency of abnormal urinalyses in healthy individuals, and it found that over a third of asymptomatic women had at least 1+ leukocytes in their urine [4]. This is evidence that a substantial number of people who do not have symptomatic UTIs have UAs that could be interpreted as UTIs. If these results could be replicated and expanded to include a wider group of individuals (males, elderly patients, various races, etc.), it would provide valuable information about how we can better interpret and utilize the results of a UA.

Thus, the investigators propose a prospective study to assess the frequency of abnormal UAs in a wide variety of individuals without acute symptoms.

Urine samples will be obtained from adults with no acute symptoms, and performed urine dipsticks to assess the frequency of leukocytes or nitrites in the urine. Patients will be divided into groups to determine if there are certain factors (gender, age, or medical history) that increase the chance of having leukocytes or nitrites in the urine.

02

Conditions studied

  • Asymptomatic Bacteriuria
  • Asymptomatic Pyuria

Browse trials for

03

In context

Bacteriuria

51 studies on the registry are indexed under Bacteriuria; 3 are open to participants now.

Browse Bacteriuria studies →

Lead sponsor

Kendall Healthcare Group, Ltd. is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Subjects are all healthy volunteers, who are primarily family, friends, or acquaintances of study investigators.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age > 18 years
  • Able to spontaneously provide a urine sample

Exclusion criteria

Exclusion Criteria:

  • Any acute symptoms (including but not limited to vaginal bleeding, vaginal discharge, abdominal pain, back pain, dysuria, hematuria, and fever)
  • Pregnancy
  • Prisoner status
  • Antibiotics within 72 hours
  • Urologic procedure within a week
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (actual)
Patient registry
No

Groups and cohorts

  • Asymptomatic Male Volunteers

    These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are male.

    Diagnostic Test: Urine dipstick test

  • Asymptomatic Female Volunteers

    These are subjects over the age of 18 who have no acute symptoms, volunteered to provide a urine sample, and are female.

    Diagnostic Test: Urine dipstick test

Interventions

  • Diagnostic testUrine dipstick test

    A sample of urine will be tested using a Mission Urinalysis Reagent Strip.

06

What researchers measure

Primary outcomes

  1. False Positive Urine

    A urine sample with at least 1+ leukocytes or positive nitrites on urine dipstick test will be considered a "false positive urine".

    Time frame: The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.

Secondary outcomes

  1. Incidental Hematuria

    A urine sample with any blood on urine dipstick test will be considered to have "incidental hematuria"

    Time frame: The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.

07

Results

Posted Jun 18, 2020

Participant flow

Participant flow — Overall Study
MilestoneAsymptomatic Male VolunteersAsymptomatic Female Volunteers
Started96104
Completed96104
Not completed00

Outcome measures

PrimaryFalse Positive Urine

A urine sample with at least 1+ leukocytes or positive nitrites on urine dipstick test will be considered a "false positive urine".

Time frame:
The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.
Reported as:
Count of participants · Participants
False Positive Urine
ParticipantsAsymptomatic Male VolunteersAsymptomatic Female Volunteers
False Positive Urine640
SecondaryIncidental Hematuria

A urine sample with any blood on urine dipstick test will be considered to have "incidental hematuria"

Time frame:
The urine is tested immediately, and results are available two minutes after placing the reagent strip in the urine.

Results for this outcome have not been posted.

Adverse events

Collected over During urine specimen collection and survey completion (about 5 minutes). Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Asymptomatic Male Volunteers0/96 (0%)0/96 (0%)0/96 (0%)
Asymptomatic Female Volunteers0/104 (0%)0/104 (0%)0/104 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Asymptomatic Male VolunteersAsymptomatic Female VolunteersTotal
Mean46.2 ± 21.753.7 ± 23.650.1 ± 23.0
Sex: Female, Male
Sex: Female, Male(Participants)Asymptomatic Male VolunteersAsymptomatic Female VolunteersTotal
Female0104104
Male96096
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Asymptomatic Male VolunteersAsymptomatic Female VolunteersTotal
American Indian or Alaska Native000
Asian6410
Native Hawaiian or Other Pacific Islander000
Black or African American448
White8696182
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Asymptomatic Male VolunteersAsymptomatic Female VolunteersTotal
United States96104200
08

Study locations

1 site
  • Kendall Regional Medical Center
    Miami, Florida 33175, United States
09

References and documents

Publications

  • Hooton TM, Scholes D, Stapleton AE, Roberts PL, Winter C, Gupta K, Samadpour M, Stamm WE. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med. 2000 Oct 5;343(14):992-7. doi: 10.1056/NEJM200010053431402. PubMed 11018165 ↗
  • Kunin CM, McCormack RC. An epidemiologic study of bacteriuria and blood pressure among nuns and working women. N Engl J Med. 1968 Mar 21;278(12):635-42. doi: 10.1056/NEJM196803212781201. No abstract available. PubMed 4866351 ↗
  • Nicolle LE. Asymptomatic bacteriuria in institutionalized elderly people: evidence and practice. CMAJ. 2000 Aug 8;163(3):285-6. No abstract available. PubMed 10951726 ↗
  • Frazee BW, Enriquez K, Ng V, Alter H. Abnormal urinalysis results are common, regardless of specimen collection technique, in women without urinary tract infections. J Emerg Med. 2015 Jun;48(6):706-11. doi: 10.1016/j.jemermed.2015.02.020. Epub 2015 Apr 1. PubMed 25841289 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2019 to primary completion in Dec 2019, 5 months.

Results were first posted in Jun 2020, 5 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2019
First posted
Aug 14, 2019
StartActual
Jul 3, 2019
Primary completionActual
Dec 30, 2019
CompletionActual
Jan 2, 2020
Results first posted
Jun 18, 2020
Last update
Jun 18, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 18, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04055675
Lead sponsor
Kendall Healthcare Group, Ltd.
Responsible party
Sponsor
First posted
Aug 14, 2019
Start date
Jul 3, 2019
Primary completion
Dec 30, 2019
Completion
Jan 2, 2020
Results posted
Jun 18, 2020
Last update
Jun 18, 2020

Study contacts

Tony Zitek, MD
study director · Nova Southeastern University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion